Dr. Shiv Rao is the CEO and Cofounder of Abridge, the leading AI platform for healthcare. Abridge is projected to support more than 100 million patient-clinician encounters in 2026 across 300 of the largest and most complex health systems in the U.S. The company developed the first AI-native clinical intelligence platform—built for clinicians, and designed to help health systems coordinate the clinical, financial, and evidence-based decisions that shape every moment of care.

A practicing cardiologist turned entrepreneur, Dr. Rao brings a combination of clinical rigor, enterprise-scale leadership, and AI product innovation to the transformation of healthcare delivery. He was named one of TIME's 100 Most Influential People in AI and has been recognized on Modern Healthcare's 100 Most Influential People in Healthcare list for two consecutive years. He also appears on the Forbes 250 America's Greatest Innovators list.

Dr. Rao continues to practice cardiology, grounding his work at Abridge in the realities of clinical care. He previously led UPMC's provider-facing investment portfolio, backing early-stage healthcare startups and helping fund a Machine Learning in Health program at Carnegie Mellon University.

Dr. Rao completed his medical education and training at the University of Michigan and the University of Pittsburgh School of Medicine. He also studied at Carnegie Mellon University, where he programmed virtual synthesizers and skateboarded in IMAX movies.

Abridge has been recognized among the most innovative companies in the industry, earning placements on the Forbes AI 50, Fortune AI 50, and Fast Company's Most Innovative Companies lists, as well as TIME's Best Inventions of 2024 and 2025.